Japan
Olympus to Acquire Korean Gastrointestinal Stent Company Taewoong Medical Co., Ltd
Olympus Corporation (Olympus), a global medtech company committed to making people's lives healthier, safer and more fulfilling, has agreed to acquire Taew...
February 24, 2023 | News
Ajinomoto Bio-Pharma Services Successfully Develops Highly Functional Ancestral RNA Ligase
In collaboration with researchers from the University of Shizuoka, Aji Bio-Pharma succeeded in developing a highly functional artificial RNA ligase using t...
February 23, 2023 | News
Nippon Express Singapore obtains IATA CEIV Pharma for Changi facility
The pharmaceutical/medical sector, one of Singapore's priority industries, has seen remarkable growth, and many of the world's leading pharmaceut...
February 22, 2023 | News
Recce Pharmaceuticals Announces RECCE® Trademark Registered in Hong Kong
Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) (the Company), the Company developing a new class of synthetic anti-infectives, today announced that it has ...
February 03, 2023 | News
Lecanemab Receives Priority Review Status in Japan
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Chri...
January 30, 2023 | News
Strength in sustainability: Vetter wins gold in EcoVadis ranking
Vetter among the top five percent in the industry Result acknowledges strong sustainability commitment to the environment, social sector and...
January 18, 2023 | News
Eisai Files Marketing Authorization Application for Anti-Amyloid-Beta Protofibril Antibody Lecanemab for Early Alzheimer's Disease in Japan
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Mass...
January 16, 2023 | News
Ajinomoto and Exelixis Enter Into a License Agreement to Discover and Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer
Exelixis is a commercially successful, oncology-focused biotechnology company that strives to accelerate the discovery, development and commercialization o...
January 11, 2023 | News
Ubitus and Smart Surgery enable doctors to practice robotic surgery with VR streaming
Immersive simulation surgery practice with VR gears Ample practices are required for a medical student or even a doctor to become a skillful surgeon opera...
December 23, 2022 | News
Eisai and Washington University School of Medicine in St. Louis Enter Into Comprehensive Research Collaboration Agreement Aiming to Create New Therapies for Neurodegenerative Diseases
Washington University is world leading in research on prevention, diagnosis, biomarkers and treatment of neurodegenerative diseases. The two organizations ...
December 15, 2022 | News
Merck Signs MoU with Synplogen to Accelerate Development and Manufacturing of Viral Vector-based Gene Therapy Applications
Merck’s Millipore® CTDMO Services (Contract Testing, Development and Manufacturing Organization) to streamline viral vector development and pro...
December 14, 2022 | News
Olympus to Join Government Project to Verify Dissemination of Endoscopic AI Diagnosis in Vietnam
Olympus Corporation (Olympus), a global medtech company committed to making people's lives healthier, safer and more fulfilling, today announced their part...
December 06, 2022 | News
Inventia enters into a distribution agreement for RASTRUM™ with SCRUM Inc in Japan
RASTRUM™, is a game-changing 3D cell culture platform that’s accelerating the quest to cure cancer and debilitating diseases. With applications...
December 05, 2022 | News
Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema
Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, announced today that ...
December 02, 2022 | News
Most Read
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
